MEF2C and hepatocellular carcinoma: Similarly, in hepatocellular carcinoma, MEF2C-silenced cells appeared to counteract the migratory effect caused by vascular endothelial growth factor (VEGF) overexpression, by maintaining the percentage of the wound area [16].